CONFERENCE NEWS
October 04, 2019. 12:00 PM CDT.
Overall survival longer for encorafenib, cetuximab, and binimetinib combo versus standard therapy
Read article
OTHER CONFERENCE NEWS
May 20, 2019
Eighty-six percent of pediatric patients with BB ingestion had visual evidence of mucosal damage
May 17, 2019
Adolescents significantly more likely to have remission of type 2 diabetes and hypertension
May 13, 2019
Risk greater for those aged 18 years and up, Caucasians, African-Americans, Asians
May 10, 2019
Patients were predicted to achieve their minimum weight at 24 months after ESG
May 08, 2019
Intervention linked to better short-term outcomes versus surgical procedures
April 25, 2019
Real-time risk score predicts incisional hernias following abdominal surgery
April 18, 2019
SSI rates differ by gender for certain procedures, including increased risk for women after heart surgery
April 17, 2019
Hand hygiene compliance was 50.8 percent when health care workers moved from dirtier to cleaner tasks
April 12, 2019
Within Avon Longitudinal Study cohort, 2.4 percent of young adults had fibrosis; 20.8 percent had steatosis
April 11, 2019
NAFLD becoming increasingly important cause of liver disease, liver mortality
April 01, 2019
Twenty-eight percent of pancreatic cancer deaths due to higher BMI in those born in 1970 to 1974
March 28, 2019
Compared with fluoroscopic guidance, VR reduces time to select GDA, splenic, right hepatic artery
February 28, 2019
Most patients are diagnosed at advanced stages of disease, report waiting months before seeing doctor
February 11, 2019
Only 30 percent of patients reported prior counseling; most interested in receiving more information
February 08, 2019
Second study highlights importance of recognizing the emotional impact of ulcerative colitis
